These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 21702649)

  • 21. PHARMAC responds on long-acting inhalers for COPD.
    Metcalfe S; Dougherty S
    N Z Med J; 2005 Nov; 118(1225):U1743. PubMed ID: 16286950
    [No Abstract]   [Full Text] [Related]  

  • 22. Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice?
    Jones PW
    Am J Respir Crit Care Med; 2009 Oct; 180(8):689-90. PubMed ID: 19805796
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-acting inhaled bronchodilators for COPD--lack of logic continues.
    Jones D
    N Z Med J; 2005 Sep; 118(1222):U1669. PubMed ID: 16222360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Asthma: new insights and advances in treatment].
    Haasler I; Buhl R; Taube C
    Dtsch Med Wochenschr; 2011 Feb; 136(5):198-200. PubMed ID: 21271481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? Yes.
    Cazzola M; Matera MG
    Chest; 2018 Oct; 154(4):746-748. PubMed ID: 30290925
    [No Abstract]   [Full Text] [Related]  

  • 26. Bifunctional Drugs for the Treatment of Respiratory Diseases.
    Page C; Cazzola M
    Handb Exp Pharmacol; 2017; 237():197-212. PubMed ID: 27787715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of inhaled tiotropium in asthma, uncontrolled with standard combination therapy.
    Antoniu SA; Antohe I
    Expert Opin Pharmacother; 2013 May; 14(7):967-9. PubMed ID: 23514606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COUNTERPOINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? No.
    Barrecheguren M; Miravitlles M
    Chest; 2018 Oct; 154(4):749-751. PubMed ID: 30290926
    [No Abstract]   [Full Text] [Related]  

  • 29. Correct use of inhalers for COPD.
    Med Lett Drugs Ther; 2017 Apr; 59(1518):e67-e71. PubMed ID: 28377554
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical burden of illness among patients with severe eosinophilic COPD.
    Müllerová H; Meeraus WH; Galkin DV; Albers FC; Landis SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():741-755. PubMed ID: 31114180
    [No Abstract]   [Full Text] [Related]  

  • 31. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC; Marchand-Adam S; Mankikian J; Diot P
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pragmatic approach to simplify inhaler therapy for COPD.
    Lipworth B; Jabbal S
    Lancet Respir Med; 2017 Sep; 5(9):679-681. PubMed ID: 28693987
    [No Abstract]   [Full Text] [Related]  

  • 33. Perplexing mortality data from triple therapy trials in COPD.
    Suissa S
    Lancet Respir Med; 2021 Jul; 9(7):684-685. PubMed ID: 34126054
    [No Abstract]   [Full Text] [Related]  

  • 34. Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal.
    Barnes PJ; Nicolini G; Bizzi A; Spinola M; Singh D
    Allergy Asthma Proc; 2012; 33(2):140-4. PubMed ID: 22525390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Side effects of bronchodilator and asthma medications].
    Hirose T; Adachi M
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():259-65. PubMed ID: 23156518
    [No Abstract]   [Full Text] [Related]  

  • 36. [What helps for persistent symptoms of asthma during inhalative steroid therapy?].
    Kroegel C
    Dtsch Med Wochenschr; 2011 Oct; 136(42):2130. PubMed ID: 21990055
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycopyrrolate/formoterol (Bevespi Aerosphere) for COPD.
    Med Lett Drugs Ther; 2016 Oct; 58(1505):130-132. PubMed ID: 27701364
    [No Abstract]   [Full Text] [Related]  

  • 39. Switching treatments in COPD: implications for costs and treatment adherence.
    Braido F; Lavorini F; Blasi F; Baiardini I; Canonica GW
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2601-8. PubMed ID: 26664108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ICS not indicated in the early stage].
    Einecke D
    MMW Fortschr Med; 2015 Dec; 157(21-22):85. PubMed ID: 26960883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.